Sign in
CompletedNo phase

Clinical Effectiveness Of High Frequency Chest Wall Oscillation (HFCWO) In A Bronchiectasis Population

Key facts

Who runs it
Electromed, Inc.
Where
Atlanta, Birmingham, Philadelphia, and Tyler, United StatesSee the 4 sites
Trial code
Status
Completed
People taking part
25 people enrolled
Started
18 Feb 2020
Ended
1 Dec 2023
Type of study
Observational
Treatments tested
  • SmartVest Airway Clearance System
Record updated
7 December 2023

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • 18 years of age or older
  • Previous diagnosis of bronchiectasis confirmed by HRCT within the last 6 months
  • Patients must have at least 6 months of medical records related to bronchiectasis
  • Patients must be stable and currently on a standard of care regimen for bronchiectasis such as hypertonic saline and/or PEP
  • Patients with 1 or more exacerbations within the last 12 months
  • Previous and existing productive cough
  • No previous HFCWO use

Who cannot take part

  • Patients with chronic obstructive pulmonary disease (COPD) without bronchiectasis
  • Patients who are known to have cystic fibrosis
  • Patients who are known to have primary ciliary dyskinesia (PCD)
  • Patients breathing via an artificial airway
  • Severe bronchospasm based on exam or history
  • Any comorbidity(ies) or contraindications that would normally complicate tolerating HFCWO treatment

Where in United States

  • Emory University School of MedicineAtlanta, United States
  • University of Alabama - Birmingham (UAB University Hospital)Birmingham, United States
  • Temple UniversityPhiladelphia, United States
  • The University of Texas Health Science Center at TylerTyler, United States

About the trial

What the trial wants to find out

The primary objective is to compare the patient's baseline QoL prior to HFCWO use against the patient's QoL at various study timepoints over a one-year period of HFCWO use.

Treatments tested

  • SmartVest Airway Clearance System

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
7 December 2023